Thanks to a commercial partnership with Rohto Pharmaceutical Co. Ltd, Freia Farmaceutici is also present in dermocosmetics with a commercial network dedicated to that therapeutic area.
Promedial line, exclusively distributed by Freia Farmaceutici, have ample diffusion in the branch of aesthetic medicine. Innovative active ingredients and quality of cosmetic formulations make Promedial line particularly suitable after dermocosmetics treatments, such as post-laser and post-peeling treatments.
Among the clinical studies published to highlight Promedial efficacy, in 2018 a clinical study entitled ” Skin hydration with a topical biomaterial ”was published in Prime journal. This study was carried out by the Italian Scientific Society of Aesthetic Medicine AGORÀ, under Professor Massirone, president of Agorà, and Professor Lazzari supervision.
